Boston Scientific Corp (XTER:BSX)
€ 87 1.5 (1.75%) Market Cap: 126.63 Bil Enterprise Value: 134.92 Bil PE Ratio: 75.00 PB Ratio: 6.46 GF Score: 79/100

Boston Scientific Corp at Stifel Healthcare Conference Transcript

Nov 19, 2019 / 04:30PM GMT
Frederick Allen Wise
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst

Good morning, again. I think it's still morning. If not, good afternoon. A little early. I am thrilled, as always, to welcome my friends from Boston Scientific: Dan Brennan, Executive Vice President and Chief Financial Officer; and Susie Lisa, the wonderful Head of Investor Relations at Boston Scientific.

Questions & Answers

Frederick Allen Wise
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst

And Dan, just there's so many topics. Let's just quickly just before we dive into the topics du jour and some of the specific growth drivers, let's just talk briefly at a high level about some of the puts and takes as we think about next year. I mean you -- first half of '19 was not what you wanted. You're accelerating as expected -- thank you -- in the second half, you've got easy comps to start out next year, tougher now, hopefully, for the full second half of 2020. But just

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot